GeneDx Holdings Corp. (NAS: WGS) Stock Analysis & Fundamentals | ScreenerHero

Create free account

WGSGeneDx Holdings Corp.

NAS · US · Healthcare · Diagnostics & Research · genedx.com

68.65USD-0.68%Mkt Cap: 2.04B $P/E: —1d ago

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and inf…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Pricier

1M Perf

Lower

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap2.04B $

Enterprise Value2.04B $

Revenue (TTM)442.68M $

Gross Profit298.17M $

Net Income (TTM)-21.02M $

Revenue/Share15.30 USD

Last Price68.65 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)55.76

PEG—

EV/EBITDA-259.31

EV/Revenue4.60

P/S4.60

P/B6.51

EPS (TTM)-2.66

EPS (Forward)1.23

52W Range

32.2126% of range170.87

52W High170.87 USD

52W Low32.21 USD

Profitability

Gross Margin69.74%

Oper. Margin-25.61%

EBITDA Margin-1.77%

Profit Margin-4.92%

ROE-6.82%

ROA-4.01%

Growth

Revenue Growth17.40%

Earnings Growth—

Cash Flow & Leverage

Operating CF33.28M $

CapEx (TTM)19.02M $

FCF Margin0.82%

FCF Yield0.18%

Net Debt-2.49M $

Net Debt/EBITDA0.32

Balance Sheet

Debt/Equity0.37

Current Ratio3.09

Quick Ratio2.83

Book Value/Sh10.54 USD

Cash/Share5.749 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:33

Split DateMay 4, 2023

Analyst Consensus

Rating1.1 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)78.44 USD

Upside (mean)+14.3%

Target Range55.00 USD – 100.00 USD

$55.00+14.3% to mean$100.00

# Analysts9

Ownership

Shares Out.29.69M

Float18.60M

Insiders12.26%

Institutions114.64%

Short Interest

Short Ratio4.6d

Short % Float38.92%

Short % Out.20.25%

Shares Short6.01M

Short (prev mo.)4.93M

Technical

SMA 5054.88 (+25.1%)

SMA 20097.50 (-29.6%)

Beta1.97

S&P 52W Chg20.05%

Avg Vol (30d)1.10M

Avg Vol (10d)1.06M

Technical Indicators

RSI (14)65.1

MACD4.0655

MACD Signal2.7633

MACD Hist.+1.3022

BB Upper71.24 USD

BB Middle59.42 USD

BB Lower47.59 USD

BB Width39.81%

ATR (14)4.398 USD

Vol Ratio (20d)0.49x